propentofylline has been researched along with Somatoform Disorders in 1 studies
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
Excerpt | Relevance | Reference |
---|---|---|
"The present study was undertaken to determine whether propentofylline, a glial modulating agent, could both prevent the induction of mechanical allodynia and attenuate existing mechanical allodynia in a rodent L5 spinal nerve transection model of neuropathic pain." | 3.71 | Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. ( DeLeo, JA; Schubert, P; Sweitzer, SM, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sweitzer, SM | 1 |
Schubert, P | 1 |
DeLeo, JA | 1 |
1 other study available for propentofylline and Somatoform Disorders
Article | Year |
---|---|
Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Immunohistochemistr | 2001 |